Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):50-8. doi: 10.1038/nrgastro.2009.201. Epub 2009 Nov 17.
Primary iron overload is one of the most common inherited diseases worldwide. Several genetic mutations underlie the various forms of the disease, which have similar pathophysiological profiles but distinct clinical presentations. Patients with hereditary hemochromatosis absorb too much iron from the diet, which accumulates over time within parenchymal cells. This accumulation leads to eventual organ failure as a consequence of iron-mediated formation of free radicals. The mechanism underlying this excessive absorption of iron is a sensing defect caused by the reduced formation of hepcidin, the master regulator of iron homeostasis, as a consequence of mutations in the genes encoding several membrane-bound signaling molecules present on hepatocytes. A considerable number of carriers of these specific genetic mutations, however, do not develop iron overload, indicating that additional genetic and environmental factors modify the severity and clinical penetrance of disease. In affected patients, early initiation of treatment by phlebotomy can prevent organ damage. Genetic screening of first-degree relatives can be also used to identify individuals at risk. Our expanding knowledge of the regulation of iron metabolism and the role of factors that modify the severity of the disease may lead to the design of new and improved treatments.
原发性铁过载是全球最常见的遗传性疾病之一。该病有多种遗传突变,具有相似的病理生理特征,但临床表现不同。遗传性血色素沉着症患者从饮食中吸收过多的铁,这些铁随着时间的推移在实质细胞内蓄积。这种蓄积导致铁介导的自由基形成,最终导致器官衰竭。这种铁过度吸收的机制是由于编码几种存在于肝细胞表面的膜结合信号分子的基因突变,导致作为铁稳态主要调节剂的铁调素形成减少,从而导致铁吸收的感应缺陷。然而,这些特定基因突变的许多携带者并未发生铁过载,这表明其他遗传和环境因素可修饰疾病的严重程度和临床外显率。在患病患者中,早期开始通过放血治疗可以预防器官损伤。对一级亲属进行基因筛查也可用于识别高危个体。我们对铁代谢调节以及修饰疾病严重程度的因素的认识不断扩大,可能会导致新的、改进的治疗方法的设计。